The cholesterol shot you couldn’t afford is now a pill

The FDA has approved Merck’s Lipfendra, a new cholesterol-lowering pill for patients who still struggle with high cholesterol levels despite taking statins. This marks a significant shift from the previously costly and inconvenient injectable treatments, providing a more accessible and convenient option. The approval is a major milestone for those managing severe cholesterol issues, potentially improving adherence to treatment and overall heart health outcomes. This development underscores the ongoing efforts to make advanced medical treatments more accessible and patient-friendly.